Clinical Trial Update: SOF Plus DCV in Treating Chinese Treatment-experienced HCV Patients [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2 and Phase 3 clinical trials evaluating the combination of sofosbuvir and daclatasvir in Chinese patients with treatment-experienced chronic he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Daclatasvir (daclatasvir)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Humanity and Health Research Centre | Conditions: Chronic Hepatitis C Infection | Phase 2, Phase 3 | Status: COMPLETED